+ Watch NVGN
on My Watchlist
The Company is a pharmaceutical company involved in the discovery, development, manufacture and marketing of products based on the emerging field of phenolic technology.
I'm still short 1000 shares of Novogen at 4.5 and looking for a gain of at least a thousand bucks before I spit this one out. I had to laugh when the stock more than doubled from where I shorted it. I can't remember the last time a spike on a PR this weak didn't die out the same day the news came out. But of course Novogen had to be the one that had legs. 4.5 might be the new floor for now, but wait until the company decides the coast is clear for a little dilution. Meanwhile, I've decided that shorting is more fun than I thought it would be. Look for a few more nailbiters from me on the short side in the near future.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions